1.	Phase III Randomized Study of Prednisone and Cyclosporine With Versus Without Hydroxychloroquine in Patients With Newly Diagnosed Extensive Chronic Graft-Versus-Host Disease Phase: Phase III Type: Supportive care Status: Completed Age: 1 to 29 Sponsor: NCI Protocol IDs: COG-ASCT0031, CCG-S9701, NCI-P02-0213, ASCT0031, NCT00031824
2.	Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NABTT-0603 CDR0000549734, U01CA062475, ABTC-0603, NABTT-0603, 0603, NCT00486603
3.	Hydroxychloroquine in Untreated B-CLL Patients Phase: Phase II Type: Treatment Status: Temporarily closed Age: Over 18 Sponsor: Other Protocol IDs: 08-088, NCT00771056
4.	Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer Phase: Phase II Type: Treatment Status: Temporarily closed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000617998, P30CA072720, CINJ-080805, 0220080244, 080805, NCT00786682
5.	Hydroxychloroquine + Vorinostat in Advanced Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: IDD 08-52, NCT01023737